Enabling the next wave of innovative drug therapies with speciality enzymes
Pharmaceutical Technology
JUNE 29, 2022
In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market. Novozymes has a long legacy of enzyme discovery and the ability to genetically engineer these speciality enzymes to be superior. Developing best-in-class speciality enzymes.
295 
Let's personalize your content